000513 丽珠集团
已收盘 09-30 15:00:00
资讯
新帖
简况
丽珠集团连续3个交易日收盘价格涨幅偏离值累计达20.82%
财中社 · 09-29 18:44
丽珠集团连续3个交易日收盘价格涨幅偏离值累计达20.82%
丽珠集团最新公告:子公司注射用醋酸亮丙瑞林微球11.25mg获批上市
证券之星 · 09-29 17:50
丽珠集团最新公告:子公司注射用醋酸亮丙瑞林微球11.25mg获批上市
丽珠集团成交额创2025年7月24日以来新高
同花顺 · 09-29 10:29
丽珠集团成交额创2025年7月24日以来新高
9月28日丽珠集团(000513)龙虎榜数据:北向资金净买入4307.39万元
证券之星 · 09-28
9月28日丽珠集团(000513)龙虎榜数据:北向资金净买入4307.39万元
9月28日丽珠集团涨10.01%,疫苗ETF国泰基金重仓该股
证券之星 · 09-28
9月28日丽珠集团涨10.01%,疫苗ETF国泰基金重仓该股
丽珠集团涨10.01%,东海证券一周前给出“买入”评级
证券之星 · 09-28
丽珠集团涨10.01%,东海证券一周前给出“买入”评级
医药韧性凸显!药ETF华宝(562050)逆市飘红,丽珠集团涨停!医疗器械局部强势,迈瑞、联影携手走强
新浪基金 · 09-28
医药韧性凸显!药ETF华宝(562050)逆市飘红,丽珠集团涨停!医疗器械局部强势,迈瑞、联影携手走强
生物疫苗概念走高 丽珠集团涨停
南方财经网 · 09-28
生物疫苗概念走高 丽珠集团涨停
丽珠集团:2026年第一次临时股东会决议公告
证券日报 · 09-27
丽珠集团:2026年第一次临时股东会决议公告
丽珠集团最新公告:副总裁徐晓因工作调整辞职
证券之星 · 09-27
丽珠集团最新公告:副总裁徐晓因工作调整辞职
丽珠集团:徐晓辞去副总裁职位
南方财经网 · 09-27
丽珠集团:徐晓辞去副总裁职位
丽珠集团副总裁徐晓辞任,管理层年内两轮“换血”,上半年净利降逾27%
红星资本局 · 09-27
丽珠集团副总裁徐晓辞任,管理层年内两轮“换血”,上半年净利降逾27%
朱保国离任,丽珠集团结束一个时代
蓝鲸财经 · 09-25
朱保国离任,丽珠集团结束一个时代
丽珠集团(000513)9月23日主力资金净买入4322.90万元
证券之星 · 09-24
丽珠集团(000513)9月23日主力资金净买入4322.90万元
“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?
红星资本局 · 09-22
“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?
研报掘金丨东海证券:维持丽珠集团“买入”评级,业绩短期承压,新品放量可期
格隆汇 · 09-18
研报掘金丨东海证券:维持丽珠集团“买入”评级,业绩短期承压,新品放量可期
东海证券:给予丽珠集团买入评级
同花顺 · 09-18
东海证券:给予丽珠集团买入评级
丽珠集团最新公告:董事长变更为刘大平
证券之星 · 09-11
丽珠集团最新公告:董事长变更为刘大平
股市必读:丽珠集团新发布《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会活动的公告》
证券之星 · 09-11
股市必读:丽珠集团新发布《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会活动的公告》
股市必读:丽珠集团新发布《关于2026年半年度利润分配预案的公告》
证券之星 · 09-10
股市必读:丽珠集团新发布《关于2026年半年度利润分配预案的公告》
公司概况
公司名称:
丽珠医药集团股份有限公司
所属行业:
医药制造业
上市日期:
1993-10-28
主营业务:
丽珠医药集团股份有限公司的主营业务是医药产品的研发、生产及销售。公司的主要产品是化学制剂产品、原料药和中间体、中药制剂、生物制品、诊断试剂及设备。公司国内领先的产业体系完备、研产销一体化程度高的大型综合型医药企业集团,长期荣登“中国化学制药行业工业企业综合实力百强”“中国化药企业百强”等权威榜单,先后获评国家高新技术企业、国家技术创新示范企业及国家企业技术中心。
发行价格:
6.38
{"stockData":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":32.9,"timestamp":1790751810000,"preClose":32.23,"halted":0,"volume":46168173,"delay":0,"changeRate":0.0208,"floatShares":568000000,"shares":888000000,"eps":1.8858,"marketStatus":"已收盘","change":0.67,"latestTime":"09-30 15:00:00","open":31.65,"high":33.38,"low":31.17,"amount":1506000000,"amplitude":0.0686,"askPrice":32.9,"askSize":189,"bidPrice":32.89,"bidSize":22,"shortable":0,"etf":0,"ttmEps":1.8858,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":32.23,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":35.45,"lowLimit":29.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":887907171,"isCdr":false,"pbRate":2.14,"roa":"--","peRate":17.446177,"roe":"6.64%","epsLYR":2.27,"committee":-0.110968,"marketValue":29212000000,"turnoverRate":0.0813,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-10-08。","hkstockBrief":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":22.72,"timestamp":1790755707003,"preClose":21.94,"halted":0,"volume":4386112,"delay":0,"premium":"-40.87"},"floatMarketCap":18676000000},"requestUrl":"/m/hq/s/000513/wiki","defaultTab":"wiki","newsList":[{"id":"2671215272","title":"丽珠集团连续3个交易日收盘价格涨幅偏离值累计达20.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215272","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671215272?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:44","pubTimestamp":1790678640,"startTime":"0","endTime":"0","summary":"9月29日,丽珠集团(000513/01513)发布公告,公司股票在9月24日、28日及29日连续3个交易日,收盘价格涨幅偏离值累计达到20.82%。2026年中期,丽珠集团实现收入50.00亿元,归母净利润9.32亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609293886583521.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609293886583521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000513","BK0187","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671189712","title":"丽珠集团最新公告:子公司注射用醋酸亮丙瑞林微球11.25mg获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2671189712","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671189712?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:50","pubTimestamp":1790675423,"startTime":"0","endTime":"0","summary":"丽珠集团(000513.SZ)公告称,公司控股子公司上海丽珠制药收到国家药监局核准签发的《药品补充申请批准通知书》,注射用醋酸亮丙瑞林微球11.25mg(3个月剂型)获批上市。该药品为化学药品注射剂,用于绝经前乳腺癌、前列腺癌及中枢性性早熟。截至目前,该药品累计研发投入约9405.48万元。国内仅上海丽珠持有该剂型批文,2025年国内3个月长效GnRHa缓释制剂终端销售额占比27%。此次获批填补国内技术空白,实现公司该产品规格全覆盖。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900029685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","BK0028","BK0187","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671262921","title":"丽珠集团成交额创2025年7月24日以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2671262921","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671262921?lang=zh_cn&edition=full","pubTime":"2026-09-29 10:29","pubTimestamp":1790648940,"startTime":"0","endTime":"0","summary":"数据宝统计,截至09:59,丽珠集团成交额10.33亿元,创2025年7月24日以来新高。最新股价上涨8.57%,换手率5.73%。上一交易日该股全天成交额为8.43亿元。据天眼查APP显示,丽珠医药集团股份有 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260929/c680349938.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260929/c680349938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0239","BK0188","000513","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670356202","title":"9月28日丽珠集团(000513)龙虎榜数据:北向资金净买入4307.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670356202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670356202?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:52","pubTimestamp":1790589170,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年9月28日公布的交易公开信息显示,丽珠集团因日涨幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月28日收盘,丽珠集团报收于30.34元,上涨10.01%,涨停,换手率4.92%,成交量27.94万手,成交额8.43亿元。从龙虎榜公布的当日买卖数据来看,北向资金合计净买入4307.39万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800023516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0028","000513","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670828026","title":"9月28日丽珠集团涨10.01%,疫苗ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670828026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670828026?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:48","pubTimestamp":1790585321,"startTime":"0","endTime":"0","summary":"证券之星消息,9月28日丽珠集团涨10.01%,收盘报30.34元,换手率4.92%,成交量27.94万手,成交额8.43亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为国泰基金的疫苗ETF国泰。疫苗ETF国泰目前规模为1.4亿元,最新净值0.5465,较上一交易日下跌2.39%,近一年下跌18.05%。疫苗ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800021642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159643","BK0239","BK0187","000513","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670828077","title":"丽珠集团涨10.01%,东海证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2670828077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670828077?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:48","pubTimestamp":1790585312,"startTime":"0","endTime":"0","summary":"今日丽珠集团涨10.01%,收盘报30.34元。2026年9月18日,东海证券研究员杜永宏发布了对丽珠集团的研报《公司简评报告:业绩短期承压,新品放量可期》,该研报对丽珠集团给出“买入”评级。公司成熟品种有望逐渐企稳,新产品放量可期,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的宋歌。丽珠集团个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800021639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286537","title":"医药韧性凸显!药ETF华宝(562050)逆市飘红,丽珠集团涨停!医疗器械局部强势,迈瑞、联影携手走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286537","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670286537?lang=zh_cn&edition=full","pubTime":"2026-09-28 13:11","pubTimestamp":1790572260,"startTime":"0","endTime":"0","summary":"制药板块顽强抗跌,场内唯一跟踪制药指数的药ETF华宝一度逆市飘红,创新药概念股丽珠集团涨停封板,健康元、康弘药业、普洛药业齐涨逾5%。把握超跌医药新机遇,投资工具关注:药ETF华宝:全市场唯一跟踪制药指数的ETF,“70%创新药+20%中药”独家配比,兼具创新药高成长及中药高股息。医疗ETF华宝:全市场医药医疗类ETF旗舰,Q2规模256.24亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-28/doc-initkarm3859610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","LNGR","LGHT","000513","PTH","GDOC","159883","IEIH","159938","BK1100","BK1583","BK1161","09939","MEDX","MDEV","BK0028","BK0239","AGNG","BK0187","HART","09996","RSPH","BK1574","BK1515","562050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670400427","title":"生物疫苗概念走高 丽珠集团涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2670400427","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670400427?lang=zh_cn&edition=full","pubTime":"2026-09-28 10:01","pubTimestamp":1790560860,"startTime":"0","endTime":"0","summary":"生物疫苗概念走高 丽珠集团涨停","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609283884832561.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609283884832561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159657","BK0188","000513","BK0028","BK0239","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670406880","title":"丽珠集团:2026年第一次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2670406880","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670406880?lang=zh_cn&edition=full","pubTime":"2026-09-27 20:40","pubTimestamp":1790512800,"startTime":"0","endTime":"0","summary":"证券日报网讯9月27日,丽珠集团发布公告称,公司于2026年9月24日召开2026年第一次临时股东会,审议通过《关于2026年半年度利润分配方案的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609273884497516.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609273884497516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000513","BK0187","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670408060","title":"丽珠集团最新公告:副总裁徐晓因工作调整辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2670408060","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670408060?lang=zh_cn&edition=full","pubTime":"2026-09-27 16:09","pubTimestamp":1790496572,"startTime":"0","endTime":"0","summary":"丽珠集团(000513.SZ)公告称,公司董事会于2026年9月23日收到副总裁徐晓的书面辞职报告,因工作调整安排,徐晓申请辞去副总裁职务,辞任后仍在公司担任其他职务。其辞职报告自送达董事会之日起生效,不会影响公司正常生产经营。截至公告披露日,徐晓未持有公司股票,不存在应履行而未履行的承诺事项。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092700001010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000513","BK0187","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670408097","title":"丽珠集团:徐晓辞去副总裁职位","url":"https://stock-news.laohu8.com/highlight/detail?id=2670408097","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670408097?lang=zh_cn&edition=full","pubTime":"2026-09-27 15:52","pubTimestamp":1790495554,"startTime":"0","endTime":"0","summary":"南财智讯9月27日电,丽珠集团公告,公司副总裁徐晓因工作调整申请辞去公司副总裁职务,辞任后仍在公司担任其他职务。徐晓将按照公司相关制度做好工作交接,其辞职不会影响公司正常生产经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609273884458370.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609273884458370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK0188","000513","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670408388","title":"丽珠集团副总裁徐晓辞任,管理层年内两轮“换血”,上半年净利降逾27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670408388","media":"红星资本局","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670408388?lang=zh_cn&edition=full","pubTime":"2026-09-27 13:41","pubTimestamp":1790487711,"startTime":"0","endTime":"0","summary":"红星资本局9月27日消息公司实控人朱保国因退休辞去董事长职务后,丽珠集团(000513.SZ;1513.HK)又迎来一名高管变动。9月24日,丽珠集团发布公告称,董事会于9月23日收到副总裁徐晓的书面辞职报告。因工作调整原因,徐晓申请辞去副总裁职务,辞任后仍将在公司担任其他职务。徐晓确认与董事会并无意见分歧,截至公告日未持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609273884441464.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609273884441464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK0187","BK0188","BK0028","000513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670111744","title":"朱保国离任,丽珠集团结束一个时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2670111744","media":"蓝鲸财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670111744?lang=zh_cn&edition=full","pubTime":"2026-09-25 09:28","pubTimestamp":1790299691,"startTime":"0","endTime":"0","summary":"文|《投资者网》蔡俊丽珠医药集团股份有限公司在一个承压的节点,翻开新篇章。近期,公司公告创始人朱保国离任董事长。任职期间,朱保国打造了一个家喻户晓的品牌,也在公司进入一个新周期的关键点功成身退。高管落地,大周期开局朱保国的离任,宣告丽珠集团的一个旧时代落幕。因此,本次创始人朱保国辞任董事长是公司高层密集变化的终点。未来,朱保国仍保留实控人身份,但内部培养、新上任的众骨干才是核心决策人。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1790233618713837742","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0187","BK0028","BK0239","BK0188","000513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430607","title":"丽珠集团(000513)9月23日主力资金净买入4322.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430607?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:06","pubTimestamp":1790212014,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月23日收盘,丽珠集团报收于27.73元,上涨3.66%,换手率1.82%,成交量10.31万手,成交额2.82亿元。近5日资金流向一览见下表:丽珠集团融资融券信息显示,融资方面,当日融资买入2151.42万元,融资偿还1735.61万元,融资净买入415.81万元。丽珠集团主营业务:以医药产品的研发、生产及销售为主业,产品涵盖制剂产品、原料药和中间体及诊断试剂及设备,覆盖了消化道、辅助生殖、精神及肿瘤免疫等众多治疗领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400008922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","000513","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669234144","title":"“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669234144","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669234144?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:16","pubTimestamp":1790079360,"startTime":"0","endTime":"0","summary":"红星资本局注意到,“药二代”们正密集走向台前。与“创一代”不同的是,他们大多拥有海外名校背景,进入核心管理层的方式也各不相同。今年以来,还有多位“药二代”走向台前。多家药企处于业务转型期二代接棒或面临考验值得一提的是,近期迎来“药二代”上台的上市公司,多数处于业务转型期。“药二代”走向前台,企业如何完成转型,仍有待时间验证。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-22/doc-inistexc1956967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0880133367.SGD","BK1191","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1226288170.HKD","LU1226287529.USD","LU1152091168.USD","688166","LU1807302812.USD","BK0046","BK0114","IE00BZ08YT58.USD","300298","BK0187","IE00BZ08YS42.EUR","LU1951186391.HKD","LU1328277881.USD","BK1521","HK0000165453.HKD","LU0315179316.USD","BK0102","LU1813983027.USD","IE00B543WZ88.USD","LU2039709279.SGD","01093","LU1960683339.HKD","300453","BK0028","LU0067412154.USD","LU0072913022.USD","KURE","LU1226287792.SGD","SG9999004220.SGD","LU1152091754.HKD","LU1226287875.USD","LU0314109678.HKD","IE0008368742.USD","IE0008369823.USD","LU1993786604.SGD","000513","LU0326950275.SGD","LU1226288253.USD","IE00B031HY20.USD","LU0140636845.USD","BK0239","600380","BK0251","BK0188","BK0077","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668594822","title":"研报掘金丨东海证券:维持丽珠集团“买入”评级,业绩短期承压,新品放量可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2668594822","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668594822?lang=zh_cn&edition=full","pubTime":"2026-09-18 14:50","pubTimestamp":1789714222,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","000513","161027","BK0188","BK0239","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991260","title":"东海证券:给予丽珠集团买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991260","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668991260?lang=zh_cn&edition=full","pubTime":"2026-09-18 12:16","pubTimestamp":1789704960,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对丽珠集团进行研究并发布了研究报告《公司简评报告:业绩短期承压,新品放量可期》,给予丽珠集团买入评级。丽珠集团(000513)投资要点公司业绩短期下滑。20 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260918/c680051921.shtml","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260918/c680051921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["000513","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666249265","title":"丽珠集团最新公告:董事长变更为刘大平","url":"https://stock-news.laohu8.com/highlight/detail?id=2666249265","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666249265?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:19","pubTimestamp":1789129199,"startTime":"0","endTime":"0","summary":"丽珠集团(000513.SZ)公告称,公司董事会于2026年9月11日收到朱保国书面辞职申请,因退休原因辞去董事长、非执行董事等职务。同日,公司召开第十二届董事会第四次会议,选举执行董事刘大平担任董事长,任期至第十二届董事会任期届满。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100046279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000513","BK0188","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590306","title":"股市必读:丽珠集团新发布《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590306?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:48","pubTimestamp":1789062496,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,丽珠集团报收于27.3元,下跌0.18%,换手率1.09%,成交量6.16万手,成交额1.68亿元。当日关注点交易信息汇总:9月10日主力资金净流出656.73万元,占总成交额3.91%。公司公告汇总:丽珠集团将于2026年9月15日15:30-17:00通过“全景路演”平台举行中报业绩说明会,就2026半年度业绩、公司治理及发展战略等与投资者交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000513","BK0028","BK0239","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666534221","title":"股市必读:丽珠集团新发布《关于2026年半年度利润分配预案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666534221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666534221?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:14","pubTimestamp":1788974052,"startTime":"0","endTime":"0","summary":"公司公告汇总关于2026年半年度利润分配预案的公告丽珠医药集团股份有限公司于2026年9月8日召开第十二届董事会第三次会议,审议通过2026年半年度利润分配预案。公司2026年半年度合并报表归属于母公司股东的净利润为932,199,213.06元,母公司累计未分配利润为923,366,417.69元。拟以股权登记日总股本为基数,向全体股东每10股派发现金股利10.20元(含税),预计分红总额905,665,314.42元,占合并报表净利润的97.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000001882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0239","BK0187","000513"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790861520069,"stockEarnings":[{"period":"1week","weight":0.1864},{"period":"1month","weight":0.2457},{"period":"3month","weight":0.0978},{"period":"6month","weight":0.0005},{"period":"1year","weight":-0.1041},{"period":"ytd","weight":-0.0004}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"丽珠医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"59540人(较上一季度增加0.16%)","perCapita":"9533股","listingDate":"1993-10-28","address":"广东省珠海市金湾区创业北路38号总部大楼","registeredCapital":"88790万元","survey":" 丽珠医药集团股份有限公司的主营业务是医药产品的研发、生产及销售。公司的主要产品是化学制剂产品、原料药和中间体、中药制剂、生物制品、诊断试剂及设备。公司国内领先的产业体系完备、研产销一体化程度高的大型综合型医药企业集团,长期荣登“中国化学制药行业工业企业综合实力百强”“中国化药企业百强”等权威榜单,先后获评国家高新技术企业、国家技术创新示范企业及国家企业技术中心。","listedPrice":6.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠集团(000513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠集团(000513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠集团,000513,丽珠集团股票,丽珠集团股票老虎,丽珠集团股票老虎国际,丽珠集团行情,丽珠集团股票行情,丽珠集团股价,丽珠集团股市,丽珠集团股票价格,丽珠集团股票交易,丽珠集团股票购买,丽珠集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠集团(000513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠集团(000513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}